|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 172.8 USD | +1.06% |
|
+7.27% | -4.16% |
| 05-14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
| 05-09 | Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up | MT |
BeiGene, Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 751.65 million compared to USD 447.8 million a year ago. Net loss was USD 251.15 million compared to USD 348.43 million a year ago.
Basic loss per share from continuing operations was USD 2.47 compared to USD 3.38 a year ago. Diluted loss per share from continuing operations was USD 31.33 compared to USD 43.42 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.16% | 18.08B | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -1.05% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B | |
| -24.95% | 8.23B |
BEIGENE, LTD. 